Tags

Type your tag names separated by a space and hit enter

EFFICACY OF INSULIN, HEPARIN AND FENOFIBRATE COMBINATION TREATMENT IN SEVERE HYPERTRIGLYCERIDEMIA: DOUBLE CENTER EXPERIENCE.
Acta Endocrinol (Buchar). 2019 Oct-Dec; 15(4):460-465.AE

Abstract

Context

Severe hypertriglyceridemia (SH), which calls for a triglyceride (TG) level above 1000 mg/dL, remains an important health issue. While some data exist to offer combination of heparin, insulin and fenofibrate as a reasonable treatment option, safety and benefits of this therapy have not been accurately weighted, largely due to the limited sample size of the relevant studies.

Aim

Assess the efficacy and safety of the heparin, insulin and fenofibrate combination in the treatment of patients with SH.

Patients - Methods

Patients aged ≥18 years with TG level above 1000 mg/dL and adequate organ function were included. Triglyceride levels were measured immediately before the treatment and on the 3rd and 6th days of the treatment. Treatment dosage, duration, response and side effects were assessed. Patients with hypertriglyceridemia presenting with acute pancreatitis were treated additionally with lipid apheresis.

Results

A total of 42 patients were included. Of these, 85.8% came to medical attention with some kind of secondary hypertriglyceridemia causes. The baseline median TG value of the cases was 2141.0 mg/ dL (1026-12250). There were 6 patients (14.3%) with acute pancreatitis at presentation. In patients without pancreatitis, with administration of insulin infusion, unfractionated heparin infusion and fenofibrate capsule, median TG values decreased to 921 mg/ dL (190-6400) on the 3rd day and to 437 mg/ dL (112-1950) on the 6th day of the treatment (p<0.0001, Friedman test). Potential toxicities related to insulin, heparin and fenofibrate combination treatment including hypoglycemia, hemorrhage, rise in creatine kinase levels, hepato - and nephrotoxicity were not observed.

Conclusion

In this trial involving patients with SH, our data suggest that insulin, heparin and fenofibrate combination therapy was safe and effective.

Authors+Show Affiliations

Adıyaman University Training and Research Hospital - Department of Endocrinology and Metabolism, Istanbul, Turkey.Adıyaman University Training and Research Hospital - Haydarpaşa Numune Training and Research Hospital, Department of Internal Diseases, Istanbul, Turkey.University of Health Sciences Umraniye Training and Research Hospital - Department of Internal Diseases, Istanbul, Turkey.Adıyaman University Training and Research Hospital - Department of Internal Diseases, Adıyaman, Istanbul, Turkey.Adıyaman University Training and Research Hospital - Haydarpaşa Numune Training and Research Hospital, Department of Internal Diseases, Istanbul, Turkey.Marmara University Medical School - Department of Endocrinology and Metabolism, Istanbul, Turkey.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

32377243

Citation

Ozcelik, S, et al. "EFFICACY of INSULIN, HEPARIN and FENOFIBRATE COMBINATION TREATMENT in SEVERE HYPERTRIGLYCERIDEMIA: DOUBLE CENTER EXPERIENCE." Acta Endocrinologica (Bucharest, Romania : 2005), vol. 15, no. 4, 2019, pp. 460-465.
Ozcelik S, Baş S, Ozcelik M, et al. EFFICACY OF INSULIN, HEPARIN AND FENOFIBRATE COMBINATION TREATMENT IN SEVERE HYPERTRIGLYCERIDEMIA: DOUBLE CENTER EXPERIENCE. Acta Endocrinol (Buchar). 2019;15(4):460-465.
Ozcelik, S., Baş, S., Ozcelik, M., Sarıaydın, M., Celik, M., & Gözü, H. (2019). EFFICACY OF INSULIN, HEPARIN AND FENOFIBRATE COMBINATION TREATMENT IN SEVERE HYPERTRIGLYCERIDEMIA: DOUBLE CENTER EXPERIENCE. Acta Endocrinologica (Bucharest, Romania : 2005), 15(4), 460-465. https://doi.org/10.4183/aeb.2019.460
Ozcelik S, et al. EFFICACY of INSULIN, HEPARIN and FENOFIBRATE COMBINATION TREATMENT in SEVERE HYPERTRIGLYCERIDEMIA: DOUBLE CENTER EXPERIENCE. Acta Endocrinol (Buchar). 2019 Oct-Dec;15(4):460-465. PubMed PMID: 32377243.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - EFFICACY OF INSULIN, HEPARIN AND FENOFIBRATE COMBINATION TREATMENT IN SEVERE HYPERTRIGLYCERIDEMIA: DOUBLE CENTER EXPERIENCE. AU - Ozcelik,S, AU - Baş,S, AU - Ozcelik,M, AU - Sarıaydın,M, AU - Celik,M, AU - Gözü,H, PY - 2020/5/8/entrez PY - 2020/5/8/pubmed PY - 2020/5/8/medline KW - Hypertriglyceridemia KW - fenofibrate KW - heparin KW - insulin SP - 460 EP - 465 JF - Acta endocrinologica (Bucharest, Romania : 2005) JO - Acta Endocrinol (Buchar) VL - 15 IS - 4 N2 - Context: Severe hypertriglyceridemia (SH), which calls for a triglyceride (TG) level above 1000 mg/dL, remains an important health issue. While some data exist to offer combination of heparin, insulin and fenofibrate as a reasonable treatment option, safety and benefits of this therapy have not been accurately weighted, largely due to the limited sample size of the relevant studies. Aim: Assess the efficacy and safety of the heparin, insulin and fenofibrate combination in the treatment of patients with SH. Patients - Methods: Patients aged ≥18 years with TG level above 1000 mg/dL and adequate organ function were included. Triglyceride levels were measured immediately before the treatment and on the 3rd and 6th days of the treatment. Treatment dosage, duration, response and side effects were assessed. Patients with hypertriglyceridemia presenting with acute pancreatitis were treated additionally with lipid apheresis. Results: A total of 42 patients were included. Of these, 85.8% came to medical attention with some kind of secondary hypertriglyceridemia causes. The baseline median TG value of the cases was 2141.0 mg/ dL (1026-12250). There were 6 patients (14.3%) with acute pancreatitis at presentation. In patients without pancreatitis, with administration of insulin infusion, unfractionated heparin infusion and fenofibrate capsule, median TG values decreased to 921 mg/ dL (190-6400) on the 3rd day and to 437 mg/ dL (112-1950) on the 6th day of the treatment (p<0.0001, Friedman test). Potential toxicities related to insulin, heparin and fenofibrate combination treatment including hypoglycemia, hemorrhage, rise in creatine kinase levels, hepato - and nephrotoxicity were not observed. Conclusion: In this trial involving patients with SH, our data suggest that insulin, heparin and fenofibrate combination therapy was safe and effective. SN - 1841-0987 UR - https://www.unboundmedicine.com/medline/citation/32377243/EFFICACY_OF_INSULIN,_HEPARIN_AND_FENOFIBRATE_COMBINATION_TREATMENT_IN_SEVERE_HYPERTRIGLYCERIDEMIA:_DOUBLE_CENTER_EXPERIENCE DB - PRIME DP - Unbound Medicine ER -
Try the Free App:
Prime PubMed app for iOS iPhone iPad
Prime PubMed app for Android
Prime PubMed is provided
free to individuals by:
Unbound Medicine.